• 2024
  Perraud V, Vanderhoydonck B, Bouvier G, Dias de Melo G, Kilonda A, Koukni M, Jochmans D, Rogée S, Ben Khalifa Y, Kergoat L, Lannoy J, Van Buyten T, Izadi-Pruneyre N, Chaltin P, Neyts J, Marchand A, Larrous F, Bourhy H, Mechanism of action of phthalazinone derivatives against rabies virus., Antiviral Res 2024 Apr; 224(): 105838.
• 2023
  de Melo GD, Perraud V, Alvarez F, Vieites-Prado A, Kim S, Kergoat L, Coleon A, Trüeb BS, Tichit M, Piazza A, Thierry A, Hardy D, Wolff N, Munier S, Koszul R, Simon-Lorière E, Thiel V, Lecuit M, Lledo PM, Renier N, Larrous F, Bourhy H, Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants., Nat Commun 2023 Jul; 14(1): 4485.
• 2022
  Feige L, Kozaki T, Dias de Melo G, Guillemot V, Larrous F, Ginhoux F, Bourhy H, , Susceptibilities of CNS Cells towards Rabies Virus Infection Is Linked to Cellular Innate Immune Responses., Viruses 2022 Dec; 15(1): .
• 2022
  Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F, , , Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H, Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
• 2021
  Frantz PN, Barinov A, Ruffié C, Combredet C, Najburg V, de Melo GD, Larrous F, Kergoat L, Teeravechyan S, Jongkaewwattana A, Billon-Denis E, Tournier JN, Prot M, Levillayer L, Conquet L, Montagutelli X, Tichit M, Hardy D, Fernandes P, Strick-Marchand H, Di Santo J, Simon-Lorière E, Bourhy H, Tangy F, A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters., Nat Commun 2021 Nov; 12(1): 6277.
• 2021
  de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, Marchio A, Kergoat L, Hardy D, Cokelaer T, Pineau P, Lecuit M, Lledo PM, Changeux JP, Bourhy H, , Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin., EMBO Mol Med 2021 Aug; 13(8): e14122.
• 2021
  de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, Verillaud B, Aparicio C, Wagner S, Gheusi G, Kergoat L, Kornobis E, Donati F, Cokelaer T, Hervochon R, Madec Y, Roze E, Salmon D, Bourhy H, Lecuit M, Lledo PM, , COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters., Sci Transl Med 2021 Jun; 13(596): .
• 2020
  de Melo GD, Sonthonnax F, Lepousez G, Jouvion G, Minola A, Zatta F, Larrous F, Kergoat L, Mazo C, Moigneu C, Aiello R, Salomoni A, Brisebard E, De Benedictis P, Corti D, Bourhy H, , A combination of two human monoclonal antibodies cures symptomatic rabies., EMBO Mol Med 2020 Sep; (): e12628.
• 2020
  Hellert J, Buchrieser J, Larrous F, Minola A, de Melo GD, Soriaga L, England P, Haouz A, Telenti A, Schwartz O, Corti D, Bourhy H, Rey FA, , Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein., Nat Commun 2020 01; 11(1): 596.
• 2015
  Maia L, da Cruz Landim-Alvarenga F, Taffarel MO, de Moraes CN, Machado GF, Melo GD, Amorim RM, Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses, BMC Vet. Res. 2015;11:63.
• 2014
  Melo GD, Silva JE, Grano FG, Homem CG, Machado GF, Compartmentalized gene expression of toll-like receptors 2, 4 and 9 in the brain and peripheral lymphoid organs during canine visceral leishmaniasis, Parasite Immunol. 2014 Dec;36(12):726-31.
• 2014
  Grano FG, Melo GD, Belinchón-Lorenzo S, Gómez-Nieto LC, Machado GF, First detection of Leishmania infantum DNA within the brain of naturally infected dogs, Vet. Parasitol. 2014 Aug;204(3-4):376-80.
• 2013
  Sakamoto KP, de Melo GD, Machado GF, T and B lymphocytes in the brains of dogs with concomitant seropositivity to three pathogenic protozoans: Leishmania chagasi, Toxoplasma gondii and Neospora caninum, BMC Res Notes 2013;6:226.
• 2013
  Pereira RS, Schweigert A, Dias de Melo G, Fernandes FV, Sueiro FA, Machado GF, Ki-67 labeling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostic and prognostic, BMC Vet. Res. 2013;9:83.
• 2013
  Machado GF, Melo GD, Souza MS, Machado AA, Migliolo DS, Moraes OC, Nunes CM, Ribeiro ES, Zymographic patterns of MMP-2 and MMP-9 in the CSF and cerebellum of dogs with subacute distemper leukoencephalitis, Vet. Immunol. Immunopathol. 2013 Jul;154(1-2):68-74.
• 2013
  Machado GF, Bernardi F, Hosomi FY, Peiró JR, Weiblen R, Roehe PM, Alessi AC, Melo GD, Ramos AT, Maiorka PC, Bovine herpesvirus-5 infection in a rabbit experimental model: immunohistochemical study of the cellular response in the CNS, Microb. Pathog. 2013 Apr;57:10-6.
• 2012
  Machado GF, Laranjeira MG, Schweigert A, de Melo GD, Porencephaly and cortical dysplasia as cause of seizures in a dog, BMC Vet. Res. 2012;8:246.
• 2012
  Melo GD, Seraguci TF, Schweigert A, Silva JE, Grano FG, Peiró JR, Lima VM, Machado GF, Pro-inflammatory cytokines predominate in the brains of dogs with visceral leishmaniasis: a natural model of neuroinflammation during systemic parasitic infection, Vet. Parasitol. 2013 Feb;192(1-3):57-66.
• 2012
  Grano FG, Silva JES, Melo GD, Schweigert A, Ciarlini PC, Machado GF, Visceral mast cell tumor and mastocythemia in a dog, Braz. J. Vet. Path. 2012;5(3):142-5..
• 2012
  Silva JES, Grano FG, Melo GD, Schweigert A, Ciarlini LDRP, Ciarlini PC, Machado GF, Squamous cell lung carcinoma in a cat, Braz. J. Vet. Path. 2012;5(3):133-6..
• 2012
  Melo GD, Marcondes M, Machado GF, Canine cerebral leishmaniasis: potential role of matrix metalloproteinase-2 in the development of neurological disease, Vet. Immunol. Immunopathol. 2012 Aug;148(3-4):260-6.
• 2011
  Melo GD, Machado GF, Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres, Cell Tissue Res. 2011 Dec;346(3):293-304.
• 2011
  Machado GF, Castro MB, Melo GD, Ferreira WL, Aylon EG, Alessi AC, Intravascular lymphomatosis in the central nervous system of dogs: Immunohistochemical investigation in two cases, Braz. J. Vet. Path. 2011;4(1):47-51.
• 2011
  Marangoni NR, Melo GD, Moraes OC, Souza MS, Perri SH, Machado GF, Levels of matrix metalloproteinase-2 and metalloproteinase-9 in the cerebrospinal fluid of dogs with visceral leishmaniasis, Parasite Immunol. 2011 Jun;33(6):330-4.
• 2010
  Melo GD, Marangoni NR, Marcondes M, Lima VM, Machado GF, High levels of serum matrix metalloproteinases in dogs with natural visceral leishmaniosis: a preliminary report, Vet. J. 2011 May;188(2):243-5.
• 2010
  Machado GF, Melo GD, Moraes OC, Souza MS, Marcondes M, Perri SH, Vasconcelos RO, Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis, Vet. Immunol. Immunopathol. 2010 Aug;136(3-4):340-5.
• 2009
  Melo GD, Machado GF, Choroid plexus involvement in dogs with spontaneous visceral leishmaniasis: a histopathological investigation, Braz. J. Vet. Path. 2009;2(2):69-74.
• 2009
  Melo GD, Marcondes M, Vasconcelos RO, Machado GF, Leukocyte entry into the CNS of Leishmania chagasi naturally infected dogs, Vet. Parasitol. 2009 Jun;162(3-4):248-56.